NIVF

F-1 - NewGenIvf Group Ltd (0001981662) (Filer)

3 - NewGenIvf Group Ltd (0001981662) (Issuer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor ("Investor") pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026. The restructuring eliminates the prior mandatory requirement that a significant percentage of proceeds from new capital raises be applied to prepay the notes under the Repurchase and Forbearance Agreement dated June 16, 2026, which was disclosed in the C

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

NewGen’s total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization NewGen’s agreed 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai’s recently closed Series A investment round, representing an unrealized gain of about US$8.5 million BANGKOK, July 30, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today provided an update on its strategic investment in K25.ai and the related impact on the Company’s capitalization and financial position. NewGen reported net profit attributable to shar

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

BANGKOK, July 27, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a definitive agreement to acquire an additional 3% equity interest in K25.ai at a US$250 million equity valuation. The US$7.5 million investment follows K25.ai’s successful community beta and rapidly accelerating market traction. Upon completion, NewGen’s aggregate ownership in K25.ai is expected to increase from 10% to 13%. As part of the consideration, NewGen expects to issue approximately 2.5 million Class A ordinary shares. Upon issuance, the Company’s total outstanding shares are expect

K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen’s 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million unrealized gain, expected to be booked in 2026 BANGKOK, July 23, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today highlighted that K25.ai has closed its Series A investment round with strategic support from the Singapore-based digital assets firm Amber Group. The latest round values K25.ai at a post-money valuation of US$200 million, doubling its US$100 million Pre-A valuation in under 60 days. New

Series A follows K25.ai's oversubscribed Pre-A round and accelerates its vision to make prediction markets native to live digital contentSINGAPORE, July 23, 2026 /PRNewswire/ -- K25.ai, the AI-native prediction market transforming livestreams into real-time interactive markets, today announced the closing of its Series A investment round, with strategic support from Amber Group, at a post-money valuation of US$200 million, doubling the company's valuation in under 60 days. The Series A marks another major milestone for K25.ai as it builds a new category at the convergence of artificial intelligence, live digital content, creator economies and prediction markets.K25.ai enables audiences to pr

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

Midpoint equity value for planned UAE cell sorting entity highlights significant growth runway in high-infertility, medical-tourism hotspot Senior Strategic Advisor Nadeem Malik, former CEO of Genetics and IVF Institute and President of Fairfax Cryobank, to spearhead commercialization BANGKOK, July 06, 2026 (GLOBE NEWSWIRE) -- NewGen Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced a compelling independent valuation from a Big Four global accounting firm for its planned UAE-based cell sorting and cytometry leasing business. The Report assigns a midpoint equity value of approximately US$19 million (as of May 31, 2026

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

BANGKOK, June 22, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that NewGen’s total outstanding shares now stand at 10,073,535 following share issuances in connection with its strategic share purchase agreements to acquire a 10% equity interest in K25.ai. The Company’s market capitalization reached US$7,631,710 on June 18, 2026, providing a solid foundation for future growth. Management views this market capitalization as representing a substantial discount to the Company’s net asset value of approximately US$25.98 million as of December 31, 2025. The balance sheet has been further strengthened by the Company’s subsequent US$10 m

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen's expanded stake and exclusive Asia-Pacific agency rights deepen its strategic participation in K25.ai's next phase of growth BANGKOK, June 18, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has executed an agreement for a further US$4 million strategic investment in K25.ai. The transaction completes K25.ai's US$10 million Pre-A round at a US$100 million valuation and, upon completion and satisfaction of the ap

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure Settlement to eliminate potential dilution from convertible notes and warrants Company views that this will position the Company's market capitalization to be undervalued relative to net assets BANGKOK, June 16, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that it has entered into a Repurchase and Forbearance Agreement (the "Settlement Agreement") with a significant investor (the "Investor"). Under the terms of the Settlement Agreement, NewGen will repurchase all outstandi